Literature DB >> 25755500

Long-term Branched Chain Amino Acid Supplementation Ameliorates Diethylnitrosamine-induced Liver Glutathione S-transferase-p Positivity in Zucker Fatty Rats.

Sonoko Ishizaki1, Megumi Nishiyama1, Asami Hagiwara1.   

Abstract

BACKGROUND: Obesity increases the risk of fatty liver disease and liver cancer. There are several models of obesity-associated hepatocellular carcinoma, but tumor development in these models is slow.
MATERIALS AND METHODS: We investigated Zucker fatty rats, a model of obesity and insulin resistance, to discover if diethylnitrosamine (DEN), a potent liver carcinogen, might enhance liver carcinogenesis. We also investigated the effect of branched chain amino acids (BCAA) against the development of liver cancer.
RESULTS: Incidence and number of hepatocellular carcinomas and adenomas were significantly greater in DEN-treated Zucker fatty rats than in DEN-treated lean rats. All treated Zucker fatty rats developed hepatocellular carcinoma within 16 weeks. Long-term BCAA supplementation significantly reduced expression of CyclinD1, PCNA, thymidine kinase, Bcl-2, and GST-p and increased expression of p21 in the liver. Furthermore, BCAA treatment significantly reduced the area of GST-p positive foci.
CONCLUSION: Long-term BCAA treatment may induces cell cycle arrest and apoptotic induction, thus suppressing pre-neoplastic lesions.

Entities:  

Keywords:  BCAA; BCAA, branched chain amino acids; DEN, diethylnitrosamine; DTT, dithiothreitol; FLS, fatty liver shionogi; GST-p, glutathione S-transferase P-form; HBV, hepatitis B virus; HCC, hepatocellular carcinoma; HCV, hepatitis C virus; PCNA, proliferation cell nuclear antigen; TK, thymidine kinase; hepatocellular carcinoma; obesity

Year:  2013        PMID: 25755500      PMCID: PMC3940393          DOI: 10.1016/j.jceh.2013.08.008

Source DB:  PubMed          Journal:  J Clin Exp Hepatol        ISSN: 0973-6883


  27 in total

1.  Effects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosis.

Authors:  Yasutoshi Muto; Shunichi Sato; Akiharu Watanabe; Hisataka Moriwaki; Kazuyuki Suzuki; Akinobu Kato; Masahiko Kato; Teiji Nakamura; Kiyohiro Higuchi; Shuhei Nishiguchi; Hiromitsu Kumada
Journal:  Clin Gastroenterol Hepatol       Date:  2005-07       Impact factor: 11.382

2.  Clinical comparison of branched-chain amino acid (l-Leucine, l-Isoleucine, l-Valine) granules and oral nutrition for hepatic insufficiency in patients with decompensated liver cirrhosis (LIV-EN study).

Authors:  Shunichi Sato; Akiharu Watanabe; Yasutoshi Muto; Kazuyuki Suzuki; Akinobu Kato; Hisataka Moriwaki; Masahiko Kato; Teiji Nakamura
Journal:  Hepatol Res       Date:  2005-03-23       Impact factor: 4.288

3.  Branched-chain amino acids prevent insulin-induced hepatic tumor cell proliferation by inducing apoptosis through mTORC1 and mTORC2-dependent mechanisms.

Authors:  Asami Hagiwara; Megumi Nishiyama; Sonoko Ishizaki
Journal:  J Cell Physiol       Date:  2012-05       Impact factor: 6.384

4.  High sensitivity of fatty liver Shionogi (FLS) mice to diethylnitrosamine hepatocarcinogenesis: comparison to C3H and C57 mice.

Authors:  Shuji Iwai; Takashi Murai; Susumu Makino; Wei Min; Keiichirou Morimura; Satoru Mori; Atsushi Hagihara; Shuichi Seki; Shoji Fukushima
Journal:  Cancer Lett       Date:  2006-03-29       Impact factor: 8.679

Review 5.  Improved chemotherapy for hepatocellular carcinoma.

Authors:  Huynh Cao; Hung Phan; Li-Xi Yang
Journal:  Anticancer Res       Date:  2012-04       Impact factor: 2.480

6.  Insulin resistance, steatohepatitis, and hepatocellular carcinoma in a new congenic strain of Fatty Liver Shionogi (FLS) mice with the Lep(ob) gene.

Authors:  Masahiko Soga; Setsuko Hashimoto; Yoshio Kishimoto; Tsutomu Hirasawa; Susumu Makino; Shuichiro Inagaki
Journal:  Exp Anim       Date:  2010

7.  Leptin receptor missense mutation in the fatty Zucker rat.

Authors:  M S Phillips; Q Liu; H A Hammond; V Dugan; P J Hey; C J Caskey; J F Hess
Journal:  Nat Genet       Date:  1996-05       Impact factor: 38.330

8.  Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma.

Authors:  Hashem B El-Serag; Thomas Tran; James E Everhart
Journal:  Gastroenterology       Date:  2004-02       Impact factor: 22.682

9.  Branched-chain amino acids suppress insulin-resistance-based hepatocarcinogenesis in obese diabetic rats.

Authors:  Hitoshi Yoshiji; Ryuichi Noguchi; Mitsuteru Kitade; Kosuke Kaji; Yasuhide Ikenaka; Tadashi Namisaki; Junichi Yoshii; Koji Yanase; Masaharu Yamazaki; Tatsuhiro Tsujimoto; Takemi Akahane; Hideto Kawaratani; Masahito Uemura; Hiroshi Fukui
Journal:  J Gastroenterol       Date:  2009-03-25       Impact factor: 7.527

10.  Medium-term bioassays as alternative carcinogenicity test.

Authors:  N Ito; K Imaida; S Tamano; A Hagiwara; T Shirai
Journal:  J Toxicol Sci       Date:  1998-07       Impact factor: 2.196

View more
  3 in total

1.  Associations of branched-chain amino acids with parameters of energy balance and survival in colorectal cancer patients: Results from the ColoCare Study.

Authors:  Mahmoud Delphan; Tengda Lin; David B Liesenfeld; Johanna Nattenmüller; Jürgen T Böhm; Biljana Gigic; Nina Habermann; Lin Zielske; Petra Schrotz-King; Martin Schneider; Alexis Ulrich; Hans-Ulrich Kauczor; Cornelia M Ulrich; Jennifer Ose
Journal:  Metabolomics       Date:  2018-01-31       Impact factor: 4.290

2.  A novel diet-induced murine model of steatohepatitis with fibrosis for screening and evaluation of drug candidates for nonalcoholic steatohepatitis.

Authors:  Chieko Ejima; Haruna Kuroda; Sonoko Ishizaki
Journal:  Physiol Rep       Date:  2016-11

3.  PPARγ/Pgc-1α-Fndc5 pathway up-regulation in gastrocnemius and heart muscle of exercised, branched chain amino acid diet fed mice.

Authors:  Navid Abedpoor; Farzaneh Taghian; Kamran Ghaedi; Iman Niktab; Zahra Safaeinejad; Farzaneh Rabiee; Sommayeh Tanhaei; Mohammad Hossein Nasr-Esfahani
Journal:  Nutr Metab (Lond)       Date:  2018-08-29       Impact factor: 4.169

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.